Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools: Antibodies Supplement
非人类灵长类动物体细胞基因组编辑工具评估测试中心:抗体补充剂
基本信息
- 批准号:10827650
- 负责人:
- 金额:$ 24.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-14 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAntibodiesCaliforniaCenter for Translational Science ActivitiesClinical SciencesCollaborationsCommunitiesEnsureEvaluationFosteringFutureGenomeInfrastructurePrimatesResearchResearch PersonnelResourcesTechnologyTestingTranslationsgene therapygenome editinghuman diseasenonhuman primatesomatic cell gene editingsupport toolssynergismtool
项目摘要
PROJECT SUMMARY / ABSTRACT
The Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools supports studies
with nonhuman primates that will advance the genome editing field, and significantly contributes to the future
translation of these technologies for the treatment of human disease. The Nonhuman Primate Testing Center
includes a robust team and partnerships that capitalize on major strengths including the California National
Primate Research Center, Genome Center, and Clinical and Translational Science Center. The Nonhuman
Primate Testing Center offers state-of-the-art capabilities for Somatic Cell Genome Editing (SCGE)
investigators to conduct high quality research in nonhuman primates. The Testing Center leverages a
supportive framework that has demonstrated a long-standing commitment to providing research opportunities
and collaborations to investigators nationwide. Through this powerful infrastructure the Testing Center fosters
partnerships with SCGE awardees through provision of expertise, resources, and collaborative opportunities
that accelerate their research, and ensures synergism across the SCGE Consortium and with ongoing
interactions with the Dissemination and Coordinating Center. This supplement supports a key collaborative
project that will result in new opportunities with broad applications for the gene therapy and somatic cell
genome editing fields, and will be conducted utilizing all of the capabilities of the Nonhuman Primate Testing
Center for Evaluation of Somatic Cell Genome Editing Tools.
项目摘要/摘要
非人灵长类测试中心体细胞基因组编辑工具支持研究
这将推动基因组编辑领域的发展,并对未来做出重大贡献
将这些技术转化为治疗人类疾病的技术。非人灵长类动物检测中心
包括一个强大的团队和合作伙伴关系,利用主要优势,包括加州国家
灵长类研究中心、基因组中心、临床和翻译科学中心。非人类
灵长类检测中心提供最先进的体细胞基因组编辑(SCGE)功能
研究人员在非人类灵长类动物身上进行高质量的研究。测试中心利用
表现出长期致力于提供研究机会的支持性框架
以及与全国调查人员的合作。通过这一强大的基础设施,考试中心促进
通过提供专业知识、资源和协作机会,与SCGE获奖者建立伙伴关系
这加快了他们的研究,并确保了整个SCGE联盟和正在进行的
与传播和协调中心的互动。本附录支持一项关键的协作
将为基因治疗和体细胞带来广泛应用的新机遇
基因组编辑领域,并将利用非人灵长类测试的所有能力进行
体细胞基因组编辑工具评估中心。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS J. HARTIGAN-O'CONNOR其他文献
DENNIS J. HARTIGAN-O'CONNOR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS J. HARTIGAN-O'CONNOR', 18)}}的其他基金
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 24.12万 - 项目类别:
Multi-omic understanding of the transformed host T-cell response to HIV following therapeutic vaccination
治疗性疫苗接种后转化宿主 T 细胞对 HIV 反应的多组学理解
- 批准号:
10731710 - 财政年份:2023
- 资助金额:
$ 24.12万 - 项目类别:
Center for Somatic Cell Genome Editing in Nonhuman Primates
非人类灵长类体细胞基因组编辑中心
- 批准号:
10773947 - 财政年份:2023
- 资助金额:
$ 24.12万 - 项目类别:
CCR5 immunotoxins as components of HIV cure regimens
CCR5 免疫毒素作为 HIV 治疗方案的组成部分
- 批准号:
10664839 - 财政年份:2022
- 资助金额:
$ 24.12万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 24.12万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 24.12万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 24.12万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 24.12万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 24.12万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 24.12万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 24.12万 - 项目类别: